NEVVI Medicare utilization intelligence
or

← back

Provider profile

SHAWE, TOBY M.D.

Dermatology · NPI 1851453765 · WYNDMOOR, PA

1
Groups
32
Codes · 2024
41,735
Disclosed services

SHAWE, TOBY is a Dermatology in WYNDMOOR, PA, a member of 1 medical group, who billed 32 distinct codes to Medicare Part B in 2024.

Groups: TASKER HEALTHCARE GROUP PC (NEW BRITAIN, PA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

41,735
disclosed services
32
codes billed to Medicare Part B
Prior year · CY2023 41,958 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17003 Destruction of precancer skin growth, 2-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17004 Destruction of precancer skin growth, 15 or more growths
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
11102 Biopsy of related skin growth, first growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96574 Application of light with debridement to destroy precancer skin growth
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
10060 Simple or single drainage of skin abscess
11401 Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
11303 Shaving of skin growth of body, arms, or legs, more than 2.0 cm
11900 Injection into skin growth, 1-7 growths
17111 Destruction of skin growth, 15 or more growths
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
11901 Injection into skin growth, more than 7 growths
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11103 Biopsy of related skin growth, each additional growth
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
11421 Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
11441 Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.